Abl tyrosine kinase regulates endocytosis of the epidermal growth factor receptor

Area of Science:

• Cell Biology
• Molecular Oncology
• Signal Transduction

Background:

• Ligand-activated epidermal growth factor receptor (EGFR) signaling is attenuated by endocytosis and lysosomal degradation.
• Oncogenic EGFR activation can result from uncoupling receptor endocytosis and degradation.
• The role of Abl nonreceptor tyrosine kinase in EGFR signaling remains undefined.

Purpose of the Study:

• To investigate the role of activated Abl kinase in regulating EGFR endocytosis and signaling.
• To elucidate the molecular mechanisms by which Abl influences EGFR trafficking and degradation.

Main Methods:

• Investigated the effect of activated Abl on EGFR internalization using cell-based assays.
• Performed phosphoproteomic analysis to identify Abl-mediated phosphorylation sites on EGFR.
• Utilized site-directed mutagenesis to assess the functional impact of EGFR phosphorylation on endocytosis.
• Examined the interaction between EGFR, Cbl, and Abl in response to epidermal growth factor stimulation.

Main Results:

• Activated Abl kinase significantly impairs EGFR internalization upon ligand stimulation.
• Activated Abl phosphorylates EGFR primarily at tyrosine 1173, and mutating this site restores endocytosis.
• Activated Abl inhibits Cbl-dependent EGFR downregulation by preventing Cbl accumulation at the plasma membrane and disrupting EGFR-Cbl complex formation.
• Abl promotes increased cell-surface expression of ligand-activated EGFR.

Conclusions:

• Activated Abl kinase plays a novel role in regulating EGFR endocytosis and stability.
• Abl-mediated phosphorylation of EGFR at Y1173 is critical for inhibiting EGFR internalization and degradation.
• Abl promotes EGFR signaling by enhancing its cell-surface expression and preventing its downregulation.
• The Abl/EGFR signaling axis may cooperate in the development and progression of human tumors.